These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6893298)

  • 21. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triiodothyronine-binding immunoglobulin in a patient with Grave's disease and its effect on metabolism and radioimmunoassay of triiodothyronine.
    Inada M; Nishikawa M; Naito K; Oishi M; Kurata S; Imura H
    Am J Med; 1980 May; 68(5):787-92. PubMed ID: 6892864
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitriiodothyronine antibody in patient with Hashimoto's thyroiditis.
    Plengvidhya N; Sunthornthepvarakul T; Vannasaeng S
    J Med Assoc Thai; 1997 Mar; 80(3):202-6. PubMed ID: 9175389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
    Nicoloff JT; Low JC; Dussault JH; Fisher DA
    J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease.
    Katakura M; Yamada T; Aizawa T; Hiramatsu K; Yukimura Y; Ishihara M; Takasu N; Maruyama K; Kameko M; Kanai M
    J Clin Endocrinol Metab; 1987 Mar; 64(3):405-8. PubMed ID: 3493254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithyrotropin antibodies in the sera of Graves' disease patients.
    Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
    J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
    Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
    Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibody against diiodinated tyrosine-gastrin in a patient with Graves' disease.
    Noguchi M; Adachi H; Aoki E; Iida Y; Kasagi K; Endo K; Konishi J; Torizuka K
    Clin Chem; 1987 Jan; 33(1):97-9. PubMed ID: 3802502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.
    Chou FF; Wang PW; Sheen-Chen SM
    J Endocrinol Invest; 1994 Jan; 17(1):41-4. PubMed ID: 7911812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.